Follow the Bliss GVS Pharma Limited share price and the full insider trade history of the company, a publicly traded company based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Bliss GVS Pharma Limited has logged 32 reports. Market capitalisation: €49.5bn. The latest transaction was filed on 19 December 2025 (Purchase). Among the most active insiders: Mr. Gagan Harsh Sharma. The full history is openly available.
32
Insider Decl.
n/a
Thresholds
€5m
31 ops.
Buy Volume
€2m
1 ops.
Sell Volume
19Σ signal
Buys €5m€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,628 of 29,062 companies
58.3
score / 100
Value
39
Quality
77
FCF yld1.7%
Earn yld2.6%
EV/EBITDA21.9x
ROE12%
Gross mgn54%
Net mgn14%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
260,000 shares@ ₹79.499312.4% of flowEquity SharesSEBI:2aef35f54220fd345e21294ed2a09eba7197dd24
25 of 32 declarations
About Bliss GVS Pharma Limited
Bliss GVS Pharma Limited is a company focused on the healthcare and pharmaceutical sector, providing a range of pharmaceutical products. It is listed on the XBOM.